BCL2L11 and mantle cell lymphoma: CUDC‐907 treatment increased Bim transcripts, suggesting that up‐regulation of Bim was likely through a transcriptional mechanism mediated by the HDACI moiety of CUDC‐907, as reported by Sílvia et al who indicated that HDACI is able to acetylate the Bim promoter and trigger its transcriptional activation in Mantle cell lymphoma.51